A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles

Trial Profile

A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Nov 2017

At a glance

  • Drugs Drospirenone (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Sponsors Leon Farma
  • Most Recent Events

    • 14 Nov 2017 Planned End Date changed from 15 Oct 2017 to 15 Mar 2018.
    • 04 Oct 2017 Planned End Date changed from 1 Oct 2017 to 15 Oct 2017.
    • 18 Nov 2016 Planned End Date changed from 1 Jul 2017 to 1 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top